Takeda Pharmaceutical Company Limited (4502.T)
Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
At close: 03:15PM JST
| Previous close | 4,173.00 |
| Open | 4,206.00 |
| Bid | 4,199.00 x 0 |
| Ask | 4,203.00 x 0 |
| Day's range | 4,186.00 - 4,248.00 |
| 52-week range | 3,900.00 - 4,873.00 |
| Volume | |
| Avg. volume | 4,160,559 |
| Market cap | 6.593T |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | 46.19 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 196.00 (4.70%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
- Bloomberg
Blackstone Is Considering the Sale of Alinamin Pharmaceutical, Sources Say
(Bloomberg) -- Blackstone Inc. is considering a sale of Japanese consumer health-care firm Alinamin Pharmaceutical Co., which used to be owned by Takeda Pharmaceutical Co., according to people familiar with the situation.Most Read from BloombergKey Engines of US Consumer Spending Are Losing Steam All at OnceGameStop Shares Surge as Gill’s Reddit Return Shows Huge BetMnuchin Chases Wall Street Glory With His War Chest of Foreign MoneyHomebuyers Are Starting to Revolt Over Steep Prices Across USAM
- Investor's Business Daily
Catalyst's New CEO Has Big Ideas For The Small Biotech
Richard Daly has watched Catalyst Pharmaceuticals transform. Now, as the company's new CEO, he has some metamorphic ideas of his own.
- GuruFocus.com
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
Comprehensive Analysis of Q1 2024 Earnings and Strategic Developments
© 2024 Yahoo. All rights reserved.